{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:36:47Z","timestamp":1783723007849,"version":"3.55.0"},"reference-count":90,"publisher":"Pharmaceutical Society of Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,3,1]]},"DOI":"10.1248\/bpb.b23-00640","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T22:17:03Z","timestamp":1740781023000},"page":"205-212","source":"Crossref","is-referenced-by-count":9,"title":["Unique and Ingenious Mechanisms Underlying Antimicrobial Resistance and Spread of <i>Haemophilus influenzae<\/i>"],"prefix":"10.1248","volume":"48","author":[{"given":"Takeaki","family":"Wajima","sequence":"first","affiliation":[{"name":"Department of Microbiology, Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468\u20138503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468\u20138503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei-ichi","family":"Uchiya","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468\u20138503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) O\u2019Neill J. \u201cTackling drug-resistant infections globally: final report and recommendations. The Review on Antimicrobial Resistance., (2016).\u201d: <https:\/\/amr-review.org\/sites\/default\/files\/160518_Final%20paper_with%20cover.pdf>, accessed 19 September, 2023."},{"key":"2","unstructured":"2) The Government of Japan. National action plan on antimicrobial resistance (AMR) 2023\u20132027. (2023)."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Hutchings MI, Truman AW, Wilkinson B. Antibiotics: past, present and future. Curr. Opin. Microbiol.<\/i>, 51<\/b>, 72\u201380 (2019).","DOI":"10.1016\/j.mib.2019.10.008"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Holmes AH, Moore LS, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, Guerin PJ, Piddock LJ. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet<\/i>, 387<\/b>, 176\u2013187 (2016).","DOI":"10.1016\/S0140-6736(15)00473-0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Uda K, Okubo Y, Kinoshita N, Morisaki N, Kasai M, Horikoshi Y, Miyairi I. Nationwide survey of indications for oral antimicrobial prescription for pediatric patients from 2013 to 2016 in Japan. J. Infect. Chemother.<\/i>, 25<\/b>, 758\u2013763 (2019).","DOI":"10.1016\/j.jiac.2019.03.004"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ishiwada N, Fujimaki K, Matsumoto T, et al. Nationwide surveillance of bacterial pathogens isolated from children conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2017: general overview of pathogenic antimicrobial susceptibility. J. Infect. Chemother.<\/i>, 27<\/b>, 139\u2013150 (2021).","DOI":"10.1016\/j.jiac.2020.11.020"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Zhang Y, Zhang F, Wang H, et al. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae<\/i> and Moraxella catarrhalis<\/i> isolated from community-acquired respiratory tract infections in China: results from the CARTIPS antimicrobial surveillance program. J. Glob. Antimicrob. Resist.<\/i>, 5<\/b>, 36\u201341 (2016).","DOI":"10.1016\/j.jgar.2016.03.002"},{"key":"8","unstructured":"8) Tacconelli E, Carrara E, Savoldi A, et al<\/i>. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis.<\/i>, 18<\/b>, 318\u2013327 (2018)."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Wajima T, Seyama S, Nakamura Y, Kashima C, Nakaminami H, Ushio M, Fujii T, Noguchi N. Prevalence of macrolide-non-susceptible isolates among \u03b2-lactamase-negative ampicillin-resistant Haemophilus influenzae<\/i> in a tertiary care hospital in Japan. J. Glob. Antimicrob. Resist.<\/i>, 6<\/b>, 22\u201326 (2016).","DOI":"10.1016\/j.jgar.2016.01.014"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Yamada S, Seyama S, Wajima T, Yuzawa Y, Saito M, Tanaka E, Noguchi N. \u03b2-Lactamase-non-producing ampicillin-resistant Haemophilus influenzae<\/i> is acquiring multidrug resistance. J. Infect. Public Health<\/i>, 13<\/b>, 497\u2013501 (2020).","DOI":"10.1016\/j.jiph.2019.11.003"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Tanaka E, Wajima T, Nakaminami H, Uchiya KI. Alternative quinolone-resistance pathway caused by simultaneous horizontal gene transfer in Haemophilus influenzae. J. Antimicrob. Chemother.<\/i>, 77<\/b>, 3270\u20133274 (2022).","DOI":"10.1093\/jac\/dkac312"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Tanaka E, Wajima T, Uchiya KI, Nakaminami H. Quinolone resistance is transferred horizontally via<\/i> uptake signal sequence recognition in Haemophilus influenzae. Antimicrob. Agents Chemother.<\/i>, 66<\/b>, e0196721 (2022).","DOI":"10.1128\/aac.01967-21"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D. Manual of Clinical Microbiology, 10th Edition, ASM Press, Washington, D.C. (2011).","DOI":"10.1128\/9781555816728"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Takala AK, van Alphen L, Musser JM, Geelen L, Selander RK, Eskola J, Makela PH. Bacteriologic epidemiology of Hemophilus influenzae<\/i> type b strains causing invasive infections in Finland. J. Infect. Dis.<\/i>, 160<\/b>, 237\u2013242 (1989).","DOI":"10.1093\/infdis\/160.2.237"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Tozzi AE, Salmaso S, Ciofi degli Atti ML, Panei P, Anemona A, Scuderi G, Wassilak SG. Incidence of invasive Haemophilus influenzae<\/i> type b disease in Italian children. Eur. J. Epidemiol.<\/i>, 13<\/b>, 73\u201377 (1997).","DOI":"10.1023\/A:1007320124502"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Bender JM, Cox CM, Mottice S, She RC, Korgenski K, Daly JA, Pavia AT. Invasive Haemophilus influenzae<\/i> disease in Utah children: an 11-year population-based study in the era of conjugate vaccine. Clin. Infect. Dis.<\/i>, 50<\/b>, e41\u2013e46 (2010).","DOI":"10.1086\/651165"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Sakata H, Adachi Y, Morozumi M, Ubukata K. Invasive Haemophilus influenzae<\/i> infections in children in Kamikawa subprefecture, Hokkaido, Japan, 2006-2015: the effectiveness of H. influenzae type b vaccine. J. Infect. Chemother.<\/i>, 23<\/b>, 459\u2013462 (2017).","DOI":"10.1016\/j.jiac.2017.03.019"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Suga S, Ishiwada N, Sasaki Y, Akeda H, Nishi J, Okada K, Fujieda M, Oda M, Asada K, Nakano T, Saitoh A, Hosoya M, Togashi T, Matsuoka M, Kimura K, Shibayama K. A nationwide population-based surveillance of invasive Haemophilus influenzae<\/i> diseases in children after the introduction of the Haemophilus influenzae<\/i> type b vaccine in Japan. Vaccine<\/i>, 36<\/b>, 5678\u20135684 (2018).","DOI":"10.1016\/j.vaccine.2018.08.029"},{"key":"19","unstructured":"19) Ubukata K, Morozumi M, Sakuma M, Adachi Y, Mokuno E, Tajima T, Iwata S, Group AOMSS. Genetic characteristics and antibiotic resistance of Haemophilus influenzae<\/i> isolates from pediatric patients with acute otitis media after introduction of 13-valent pneumococcal conjugate vaccine in Japan. J. Infect. Chemother.<\/i>, 25<\/b>, 720\u2013726 (2019)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Hamilton HL, Dillard JP. Natural transformation of Neisseria gonorrhoeae<\/i>: from DNA donation to homologous recombination. Mol. Microbiol.<\/i>, 59<\/b>, 376\u2013385 (2006).","DOI":"10.1111\/j.1365-2958.2005.04964.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Mell JC, Redfield RJ. Natural competence and the evolution of DNA uptake specificity. J. Bacteriol.<\/i>, 196<\/b>, 1471\u20131483 (2014).","DOI":"10.1128\/JB.01293-13"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Muschiol S, Balaban M, Normark S, Henriques-Normark B. Uptake of extracellular DNA: competence induced pili in natural transformation of Streptococcus pneumoniae. BioEssays<\/i>, 37<\/b>, 426\u2013435 (2015).","DOI":"10.1002\/bies.201400125"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Goodgal SH. DNA uptake in Haemophilus<\/i> transformation. Annu. Rev. Genet.<\/i>, 16<\/b>, 169\u2013192 (1982).","DOI":"10.1146\/annurev.ge.16.120182.001125"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Mell JC, Shumilina S, Hall IM, Redfield RJ. Transformation of natural genetic variation into Haemophilus influenzae<\/i> genomes. PLoS Pathog.<\/i>, 7<\/b>, e1002151 (2011).","DOI":"10.1371\/journal.ppat.1002151"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Redfield RJ. Genes for breakfast: the have-your-cake-and-eat-it-too of bacterial transformation. J. Hered.<\/i>, 84<\/b>, 400\u2013404 (1993).","DOI":"10.1093\/oxfordjournals.jhered.a111361"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Moradigaravand D, Engelstadter J. The evolution of natural competence: disentangling costs and benefits of sex in bacteria. Am. Nat.<\/i>, 182<\/b>, E112\u2013E126 (2013).","DOI":"10.1086\/671909"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Redfield RJ, Schrag MR, Dean AM. The evolution of bacterial transformation: sex with poor relations. Genetics<\/i>, 146<\/b>, 27\u201338 (1997).","DOI":"10.1093\/genetics\/146.1.27"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Redfield RJ. Evolution of bacterial transformation: is sex with dead cells ever better than no sex at all? Genetics<\/i>, 119<\/b>, 213\u2013221 (1988).","DOI":"10.1093\/genetics\/119.1.213"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Danner DB, Deich RA, Sisco KL, Smith HO. An eleven-base-pair sequence determines the specificity of DNA uptake in Haemophilus<\/i> transformation. Gene<\/i>, 11<\/b>, 311\u2013318 (1980).","DOI":"10.1016\/0378-1119(80)90071-2"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Goodman SD, Scocca JJ. Identification and arrangement of the DNA sequence recognized in specific transformation of Neisseria gonorrhoeae. Proc. Natl. Acad. Sci. U.S.A.<\/i>, 85<\/b>, 6982\u20136986 (1988).","DOI":"10.1073\/pnas.85.18.6982"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Mell JC, Hall IM, Redfield RJ. Defining the DNA uptake specificity of naturally competent Haemophilus influenzae<\/i> cells. Nucleic Acids Res.<\/i>, 40<\/b>, 8536\u20138549 (2012).","DOI":"10.1093\/nar\/gks640"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Smith HO, Gwinn ML, Salzberg SL. DNA uptake signal sequences in naturally transformable bacteria. Res. Microbiol.<\/i>, 150<\/b>, 603\u2013616 (1999).","DOI":"10.1016\/S0923-2508(99)00130-8"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Takahata S, Ida T, Senju N, Sanbongi Y, Miyata A, Maebashi K, Hoshiko S. Horizontal gene transfer of ftsI, encoding penicillin-binding protein 3, in Haemophilus influenzae. Antimicrob. Agents Chemother.<\/i>, 51<\/b>, 1589\u20131595 (2007).","DOI":"10.1128\/AAC.01545-06"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Mikasa K, Aoki N, Aoki Y, Abe S, Iwata S, Ouchi K, Kasahara K, Kadota J, Kishida N, Kobayashi O, Sakata H, Seki M, Tsukada H, Tokue Y, Nakamura-Uchiyama F, Higa F, Maeda K, Yanagihara K, Yoshida K. JAID\/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases\/Japanese Society of Chemotherapy - The JAID\/JSC Guide to Clinical Management of Infectious Disease\/Guideline-preparing Committee Respiratory Infectious Disease WG. J. Infect. Chemother.<\/i>, 22<\/b> (Suppl), S1\u2013S65 (2016).","DOI":"10.1016\/j.jiac.2015.12.019"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Flournoy DJ. In vitro<\/i> susceptibilities of Haemophilus influenzae<\/i> isolates from a Veterans Administration Medical Center. Med. Microbiol. Immunol.<\/i>, 173<\/b>, 303\u2013309 (1985).","DOI":"10.1007\/BF02125034"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Gutmann L, Williamson R, Collatz E, Acar JF. Mechanisms of beta-lactam resistance in Haemophilus influenzae. Eur. J. Clin. Microbiol. Infect. Dis.<\/i>, 7<\/b>, 610\u2013615 (1988).","DOI":"10.1007\/BF01964237"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Sahm DF, Jones ME, Hickey ML, Diakun DR, Mani SV, Thornsberry C. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae<\/i> and Moraxella catarrhalis<\/i> isolated in Asia and Europe, 1997\u20131998. J. Antimicrob. Chemother.<\/i>, 45<\/b>, 457\u2013466 (2000).","DOI":"10.1093\/jac\/45.4.457"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Hasegawa K, Yamamoto K, Chiba N, Kobayashi R, Nagai K, Jacobs MR, Appelbaum PC, Sunakawa K, Ubukata K. Diversity of ampicillin-resistance genes in Haemophilus influenzae<\/i> in Japan and the United States. Microb. Drug Resist.<\/i>, 9<\/b>, 39\u201346 (2003).","DOI":"10.1089\/107662903764736337"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Ubukata K, Shibasaki Y, Yamamoto K, Chiba N, Hasegawa K, Takeuchi Y, Sunakawa K, Inoue M, Konno M. Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob. Agents Chemother.<\/i>, 45<\/b>, 1693\u20131699 (2001).","DOI":"10.1128\/AAC.45.6.1693-1699.2001"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Ubukata K, Chiba N, Morozumi M, Iwata S, Sunakawa K. Working Group of Nationwide Surveillance for Bacterial M. Longitudinal surveillance of Haemophilus influenzae<\/i> isolates from pediatric patients with meningitis throughout Japan, 2000-2011. J. Infect. Chemother.<\/i>, 19<\/b>, 34\u201341 (2013).","DOI":"10.1007\/s10156-012-0448-x"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Pakyz AL, Oinonen M, Polk RE. Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother.<\/i>, 53<\/b>, 1983\u20131986 (2009).","DOI":"10.1128\/AAC.01535-08"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) White AC Jr, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin. Infect. Dis.<\/i>, 25<\/b>, 230\u2013239 (1997).","DOI":"10.1086\/514545"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Potts CC, Rodriguez-Rivera LD, Retchless AC, Buono SA, Chen AT, Marjuki H, Blain AE, Wang X. Antimicrobial susceptibility survey of invasive Haemophilus influenzae<\/i> in the United States in 2016. Microbiol. Spectr.<\/i>, 10<\/b>, e0257921 (2022).","DOI":"10.1128\/spectrum.02579-21"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Tsang RSW, Shuel M, Whyte K, Hoang L, Tyrrell G, Horsman G, Wylie J, Jamieson F, Lefebvre B, Haldane D, Gad RR, German GJ, Needle R. Antibiotic susceptibility and molecular analysis of invasive Haemophilus influenzae<\/i> in Canada, 2007 to 2014. J. Antimicrob. Chemother.<\/i>, 72<\/b>, 1314\u20131319 (2017).","DOI":"10.1093\/jac\/dkw565"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Doern GV, Brueggemann AB, Pierce G, Holley HPJr, Rauch A. Antibiotic resistance among clinical isolates of Haemophilus influenzae<\/i> in the United States in 1994 and 1995 and detection of \u03b2-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob. Agents Chemother.<\/i>, 41<\/b>, 292\u2013297 (1997).","DOI":"10.1128\/AAC.41.2.292"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Hasegawa K, Kobayashi R, Takada E, Ono A, Chiba N, Morozumi M, Iwata S, Sunakawa K, Ubukata K. Nationwide Surveillance for Bacterial M. High prevalence of type b \u03b2-lactamase-non-producing ampicillin-resistant Haemophilus influenzae<\/i> in meningitis: the situation in Japan where Hib vaccine has not been introduced. J. Antimicrob. Chemother.<\/i>, 57<\/b>, 1077\u20131082 (2006).","DOI":"10.1093\/jac\/dkl142"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Shiro H, Sato Y, Toyonaga Y, Hanaki H, Sunakawa K. Nationwide survey of the development of drug resistance in the pediatric field in 2000-2001, 2004, 2007, 2010, and 2012: evaluation of the changes in drug sensitivity of Haemophilus influenzae<\/i> and patients\u2019 background factors. J. Infect. Chemother.<\/i>, 21<\/b>, 247\u2013256 (2015).","DOI":"10.1016\/j.jiac.2014.11.012"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Tanaka E, Hara N, Wajima T, Ochiai S, Seyama S, Shirai A, Shibata M, Shiro H, Natsume Y, Noguchi N. Emergence of Haemophilus influenzae<\/i> with low susceptibility to quinolones and persistence in tosufloxacin treatment. J. Glob. Antimicrob. Resist.<\/i>, 18<\/b>, 104\u2013108 (2019).","DOI":"10.1016\/j.jgar.2019.01.017"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Tokimatsu I, Matsumoto T, Tsukada H, et al. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of the Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2019-2020: General view of the pathogens\u2019 antibacterial susceptibility. J. Infect. Chemother.<\/i>, 29<\/b>, 731\u2013743 (2023).","DOI":"10.1016\/j.jiac.2023.04.008"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Juhas M, Dimopoulou I, Robinson E, Elamin A, Harding R, Hood D, Crook D. Identification of another module involved in the horizontal transfer of the Haemophilus<\/i> genomic island ICEHin1056. Plasmid<\/i>, 70<\/b>, 277\u2013283 (2013).","DOI":"10.1016\/j.plasmid.2013.05.008"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Juhas M, Power PM, Harding RM, Ferguson DJ, Dimopoulou ID, Elamin AR, Mohd-Zain Z, Hood DW, Adegbola R, Erwin A, Smith A, Munson RS, Harrison A, Mansfield L, Bentley S, Crook DW. Sequence and functional analyses of Haemophilus<\/i> spp. genomic islands. Genome Biol.<\/i>, 8, R237<\/b> (2007).","DOI":"10.1186\/gb-2007-8-11-r237"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Mendelman PM, Chaffin DO, Kalaitzoglou G. Penicillin-binding proteins and ampicillin resistance in Haemophilus influenzae. J. Antimicrob. Chemother.<\/i>, 25<\/b>, 525\u2013534 (1990).","DOI":"10.1093\/jac\/25.4.525"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Mendelman PM, Chaffin DO, Musser JM, De Groot R, Serfass DA, Selander RK. Genetic and phenotypic diversity among ampicillin-resistant, non-\u03b2-lactamase-producing, nontypeable Haemophilus influenzae<\/i> isolates. Infect. Immun.<\/i>, 55<\/b>, 2585\u20132589 (1987).","DOI":"10.1128\/iai.55.11.2585-2589.1987"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Dabernat H, Delmas C, Seguy M, Pelissier R, Faucon G, Bennamani S, Pasquier C. Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob. Agents Chemother.<\/i>, 46<\/b>, 2208\u20132218 (2002).","DOI":"10.1128\/AAC.46.7.2208-2218.2002"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Hegstad K, Mylvaganam H, Janice J, Josefsen E, Sivertsen A, Skaare D. Role of Horizontal gene transfer in the development of multidrug resistance in Haemophilus influenzae. MSphere<\/i>, 5<\/b>, e00969\u201319 (2020).","DOI":"10.1128\/mSphere.00969-19"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Witherden EA, Bajanca-Lavado MP, Tristram SG, Nunes A. Role of inter-species recombination of the ftsI gene in the dissemination of altered penicillin-binding-protein-3-mediated resistance in Haemophilus influenzae<\/i> and Haemophilus haemolyticus. J. Antimicrob. Chemother.<\/i>, 69<\/b>, 1501\u20131509 (2014).","DOI":"10.1093\/jac\/dku022"},{"key":"57","unstructured":"57) Piscitelli SC, Danziger LH, Rodvold KA. Clarithromycin and azithromycin: new macrolide antibiotics. Clin. Pharm.<\/i>, 11<\/b>, 137\u2013152 (1992)."},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Seyama S, Wajima T, Nakaminami H, Noguchi N. Clarithromycin resistance mechanisms of epidemic \u03b2-lactamase-nonproducing ampicillin-resistant Haemophilus influenzae<\/i> strains in Japan. Antimicrob. Agents Chemother.<\/i>, 60<\/b>, 3207\u20133210 (2016).","DOI":"10.1128\/AAC.00163-16"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Seyama S, Wajima T, Nakaminami H, Noguchi N. Amino acid substitution in the major multidrug efflux transporter protein AcrB contributes to low susceptibility to azithromycin in Haemophilus influenzae. Antimicrob. Agents Chemother.<\/i>, 61<\/b>, e01337\u201317 (2017).","DOI":"10.1128\/AAC.01337-17"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Horaud T, Le Bouguenec C, Pepper K. Molecular genetics of resistance to macrolides, lincosamides and streptogramin B (MLS) in streptococci. J Antimicrob Chemother<\/i>, 16 Suppl A<\/b>, 111\u2013135 (1985).","DOI":"10.1093\/jac\/16.suppl_A.111"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Atkinson CT, Kunde DA, Tristram SG. Acquired macrolide resistance genes in Haemophilus influenzae? J. Antimicrob. Chemother.<\/i>, 70<\/b>, 2234\u20132236 (2015).","DOI":"10.1093\/jac\/dkv093"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Roberts MC, Soge OO, No DB. Characterization of macrolide resistance genes in Haemophilus influenzae<\/i> isolated from children with cystic fibrosis. J. Antimicrob. Chemother.<\/i>, 66<\/b>, 100\u2013104 (2011).","DOI":"10.1093\/jac\/dkq425"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Hara N, Wajima T, Seyama S, Tanaka E, Shirai A, Shibata M, Natsume Y, Shiro H, Noguchi N. Isolation of multidrug-resistant Haemophilus influenzae<\/i> harbouring multiple exogenous genes from a patient diagnosed with acute sinusitis. J. Infect. Chemother.<\/i>, 25<\/b>, 385\u2013387 (2019).","DOI":"10.1016\/j.jiac.2018.09.015"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Seyama S, Wajima T, Suzuki M, Ushio M, Fujii T, Noguchi N. Emergence and molecular characterization of Haemophilus influenzae<\/i> harbouring mef<\/i>(A). J. Antimicrob. Chemother.<\/i>, 72<\/b>, 948\u2013949 (2017).","DOI":"10.1093\/jac\/dkx114"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Johannessen H, Anthonisen IL, Zecic N, Hegstad K, Ranheim TE, Skaare D. Characterization and fitness cost of tn7100, a novel integrative and conjugative element conferring multidrug resistance in Haemophilus influenzae. Front. Microbiol.<\/i>, 13<\/b>, 945411 (2022).","DOI":"10.3389\/fmicb.2022.945411"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) Michel C, Argud\u00edn M, Wautier M, Echahidi F, Prevost B, Vandenberg O, Martiny D, Hallin M. Multiple interspecies recombination events documented by whole genome sequencing in multidrug resistant Haemophilus influenzae<\/i> clinical isolates. Access Microbiol.<\/i>, 6<\/b>, 000649 (2024).","DOI":"10.1099\/acmi.0.000649.v3"},{"key":"67","doi-asserted-by":"publisher","unstructured":"67) Bush NG, Evans-Roberts K, Maxwell A. DNA Topoisomerases. Ecosal Plus<\/i>, 6<\/b>, 10.1128\/ecosalplus.ESP-0010-2014 (2015)","DOI":"10.1128\/ecosalplus.ESP-0010-2014"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Sugino A, Peebles CL, Kreuzer KN, Cozzarelli NR. Mechanism of action of nalidixic acid: purification of Escherichia coli nalA<\/i> gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme. Proc. Natl. Acad. Sci. U.S.A.<\/i>, 74<\/b>, 4767\u20134771 (1977).","DOI":"10.1073\/pnas.74.11.4767"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69) Olson G, Davis AM. Diagnosis and treatment of adults with community-acquired pneumonia. JAMA<\/i>, 323<\/b>, 885\u2013886 (2020).","DOI":"10.1001\/jama.2019.21118"},{"key":"70","unstructured":"70) Ouchi K, Sunakawa K. Effect of new oral antimicrobial agents in outpatient treatment of pneumonia in children. Jpn. J. Antibiot.<\/i>, 67<\/b>, 157\u2013166 (2014)."},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Higashi T, Fukuhara S. Antibiotic prescriptions for upper respiratory tract infection in Japan. Intern. Med.<\/i>, 48<\/b>, 1369\u20131375 (2009).","DOI":"10.2169\/internalmedicine.48.1893"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72) Georgiou M, Munoz R, Roman F, Canton R, Gomez-Lus R, Campos J, De La Campa AG. Ciprofloxacin-resistant Haemophilus influenzae<\/i> strains possess mutations in analogous positions of GyrA and ParC. Antimicrob. Agents Chemother.<\/i>, 40<\/b>, 1741\u20131744 (1996).","DOI":"10.1128\/AAC.40.7.1741"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73) Hooper DC. Mechanisms of fluoroquinolone resistance. Drug Resist. Updat.<\/i>, 2<\/b>, 38\u201355 (1999).","DOI":"10.1054\/drup.1998.0068"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74) Puig C, Tirado-Velez JM, Calatayud L, Tubau F, Garmendia J, Ardanuy C, Marti S, de la Campa AG, Linares J. Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae<\/i> clinical isolates. Antimicrob. Agents Chemother.<\/i>, 59<\/b>, 461\u2013466 (2015).","DOI":"10.1128\/AAC.04005-14"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75) Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in Haemophilus influenzae. Clin. Microbiol. Rev.<\/i>, 20<\/b>, 368\u2013389 (2007).","DOI":"10.1128\/CMR.00040-06"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76) Heisig P. Genetic evidence for a role of parC<\/i> mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob. Agents Chemother.<\/i>, 40<\/b>, 879\u2013885 (1996).","DOI":"10.1128\/AAC.40.4.879"},{"key":"77","unstructured":"77) CLSI. Performance Standards for Antimicrobial Susceptibility Testing, 29th ed. CLSI, Wayne, PA. (2019)."},{"key":"78","doi-asserted-by":"crossref","unstructured":"78) Seyama S, Wajima T, Yanagisawa Y, Nakaminami H, Ushio M, Fujii T, Noguchi N. Rise in Haemophilus influenzae<\/i> with reduced quinolone susceptibility and development of a simple screening method. Pediatr. Infect. Dis. J.<\/i>, 36<\/b>, 263\u2013266 (2017).","DOI":"10.1097\/INF.0000000000001415"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79) Takeuchi N, Ohkusu M, Hoshino T, Yamamoto S, Segawa S, Murata S, Ishiwada N. Emergence of Haemophilus influenzae<\/i> with low susceptibility to quinolones isolated from pediatric patients in Japan. J. Infect. Chemother.<\/i>, 27<\/b>, 1020\u20131026 (2021).","DOI":"10.1016\/j.jiac.2021.02.022"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80) Hara N, Wajima T, Tanaka E, Noguchi N, Shirai A, Shibata M, Shiro H. Two cases in which tosufloxacin was administered for respiratory infections that may have been caused by Haemophilus influenzae<\/i> less susceptible to quinolone. Iryo Yakugaku<\/i>, 46<\/b>, 211\u2013214 (2020).","DOI":"10.5649\/jjphcs.46.211"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81) Mizoi K, Wajima T, Tanaka E, Nakaminami H, Noguchi N. Comparison of the bactericidal effects of quinolones against low-susceptible Haemophilus influenzae. J. Med. Microbiol.<\/i>, 70<\/b>, 001376 (2021).","DOI":"10.1099\/jmm.0.001376"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82) Tanaka E, Wajima T, Hirai Y, Nakaminami H, Noguchi N. Dissemination of quinolone low-susceptible Haemophilus influenzae<\/i> ST422 in Tokyo, Japan. J. Infect. Chemother.<\/i>, 27<\/b>, 962\u2013966 (2021).","DOI":"10.1016\/j.jiac.2021.02.007"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83) Tanaka E, Wajima T, Hara N, Shirai A, Shibata M, Shiro H, Noguchi N. First outbreak of Haemophilus influenzae<\/i> clone ST422 with low susceptibility to quinolones in paediatric patients in Japan. J. Med. Microbiol.<\/i>, 69<\/b>, 239\u2013243 (2020).","DOI":"10.1099\/jmm.0.001154"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84) Chang CM, Lauderdale TL, Lee HC, Lee NY, Wu CJ, Chen PL, Lee CC, Chen PC, Ko WC. Colonisation of fluoroquinolone-resistant Haemophilus influenzae<\/i> among nursing home residents in southern Taiwan. J. Hosp. Infect.<\/i>, 75<\/b>, 304\u2013308 (2010).","DOI":"10.1016\/j.jhin.2009.12.020"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85) Fuursted K, Hartmeyer GN, Stegger M, Andersen PS, Justesen US. Molecular characterisation of the clonal emergence of high-level ciprofloxacin-monoresistant Haemophilus influenzae<\/i> in the Region of Southern Denmark. J. Glob. Antimicrob. Resist.<\/i>, 5<\/b>, 67\u201370 (2016).","DOI":"10.1016\/j.jgar.2015.12.004"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86) Rodriguez-Martinez JM, Lopez L, Garcia I, Pascual A. Characterization of a clinical isolate of Haemophilus influenzae<\/i> with a high level of fluoroquinolone resistance. J. Antimicrob. Chemother.<\/i>, 57<\/b>, 577\u2013578 (2006).","DOI":"10.1093\/jac\/dki488"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87) Honda H, Sato T, Shinagawa M, Fukushima Y, Nakajima C, Suzuki Y, Kuronuma K, Takahashi S, Takahashi H, Yokota SI. In Vitro<\/i> Derivation of fluoroquinolone-resistant mutants from multiple lineages of Haemophilus influenzae<\/i> and identification of mutations associated with fluoroquinolone resistance. Antimicrob. Agents Chemother.<\/i>, 64<\/b>, e01500\u201319 (2020).","DOI":"10.1128\/AAC.01500-19"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88) Faccone D, Lopez-Ruitti P, Vazquez M, Guerriero L, Lucero C, Gagetti P, Ceriana P, Corso A. Molecular characterization of a clinical Haemophilus parainfluenzae<\/i> isolate with cefotaxime resistance and decreased susceptibility to fluoroquinolones. Infect. Genet. Evol.<\/i>, 44<\/b>, 507\u2013509 (2016).","DOI":"10.1016\/j.meegid.2016.08.003"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89) Tanaka E, Hirai Yww, Wajima T, Ishida Y, Kawamura Y, Nakaminami H. High-level quinolone-resistant haemophilus haemolyticus<\/i> in pediatric patient with no history of quinolone exposure. Emerg. Infect. Dis.<\/i>, 28<\/b>, 104\u2013110 (2022).","DOI":"10.3201\/eid2801.210248"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90) Tanaka E, Wajima T, Nakaminami H, Uchiya KI. Contribution of amino acid substitutions in ParE to quinolone resistance in Haemophilus haemolyticus<\/i> revealed through a horizontal transfer assay using Haemophilus influenzae. J. Antimicrob. Chemother.<\/i>, 78<\/b>, 1225\u20131230 (2023).","DOI":"10.1093\/jac\/dkad074"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/3\/48_b23-00640\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T03:32:09Z","timestamp":1740799929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/3\/48_b23-00640\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b23-00640","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]},"article-number":"b23-00640"}}